Early research (Phase 1)Active Not RecruitingNCT02207465
What this trial is testing
A Phase I Dual Dose Escalation Study of Radiation and Nab-Paclitaxel in Patients With Unresectable and Borderline Resectable Pancreatic Cancer
Who this might be right for
Locally Advanced Unresectable Pancreatic Cancer Treated With ChemoradiotherapyBorderline Resectable Pancreatic Cancer Treated With Chemoradiotherapy
Abramson Cancer Center at Penn Medicine 42